期刊文献+

循环vaspin水平与妊娠糖尿病的关联:系统综述与Meta分析 被引量:3

Association between circulating vaspin levels and the risk of gestational diabetes mellitus:A systematic review and Meta-analysis
原文传递
导出
摘要 目的评价循环vaspin水平与妊娠糖尿病(gestational diabetes mellitus,GDM)的关联。方法系统检索PubMed、EMBASE、Web of Science、中国知网和万方数据库。检索时间截至2019年6月。使用随机效应模型或固定效应模型,计算合并标准化均数差(standardized mean differences,SMD)及其95%置信区间(confidence interval,CI)。通过亚组分析、Meta回归分析、敏感性分析和发表偏倚分析评价结果的异质性与稳定性。所有统计分析均使用STATA 12.0软件。结果共纳入2013年至2019年期间发表的9篇文献(11个研究),涵盖738例GDM患者和661例健康孕妇。GDM患者和健康孕妇之间总体循环vaspin水平差异有统计学意义(SMD=0.613,95%CI:0.044~1.182,P=0.035)。根据vaspin水平所处的孕期和体重指数(body mass index,BMI)是否匹配进行亚组分析,其相关方向与总结果相似;按照种族进行亚组分析,发现在"欧洲人"亚组中vaspin水平与GDM可能无关;通过敏感性分析,在排除了质量中等的研究和BMI没有匹配的研究后,循环vaspin水平与GDM的关系依然存在。结论在亚洲人群中,孕产妇循环vaspin水平可能与GDM的风险呈正相关。 Objective To review the existing literature and quantitatively evaluate the association of circulating vaspin levels and the risk of gestational diabetes mellitus(GDM).Methods We systematically searched the PubMed,EMBASE,Web of Science,China National Knowledge Infrastructure,and WanfangData databases up to June 2019.Pooled standardized mean differences(SMDs)with 95%confidence intervals(CIs)were calculated using random-or fixed-effects models based on the heterogeneity of studies.Subgroup analyses,Meta-regression,sensitivity and publication bias were assessed to analyze the heterogeneity and the robustness of the results.All statistical analyses were performed using STATA 12.0.Results Nine articles(11 comparisons)published from 2013 to 2019 were included in our final Meta-analysis,covering a total of 738 patients with GDM and 661 normal pregnant women.There was significant difference in the overall maternal circulating vaspin levels between GDM patients and healthy pregnant women(SMD=0.613,95%CI:0.044-1.182,P=0.035).Subgroup analyses stratified by trimester in which vaspin was measured and whether BMI was matched suggested the similar trend to the overall result.Subgroup analysis according to ethnicity found that circulating vaspin level might not be related to GDM in"European"subgroup;sensitivity analysis by excluding moderate-quality studies and BMI-unmatched studies found that circulating vaspin levels were still related to GDM risk.Conclusions Our Meta-analysis indicated that maternal circulating vaspin levels might be positively correlated with the risk of GDM in Asians.
作者 龙斯思 马淑娟 张佳月 郭楚豪 谭红专 LONG Si-si;MA Shu-juan;ZHANG Jia-yue;GUO Chu-hao;TAN Hong-zhuan(Xiangya School of Public Health,Central South University,Changsha 410008,China)
出处 《中华疾病控制杂志》 CAS CSCD 北大核心 2020年第3期354-358,共5页 Chinese Journal of Disease Control & Prevention
基金 国家自然科学基金(81773535) 湖南省重点研发计划项目(2018SK2061)。
关键词 vaspin水平 妊娠糖尿病 BMI 系统综述 META分析 Vaspin level Gestational diabetes mellitus Body mass index Systematic review Meta-analysis
  • 相关文献

参考文献3

二级参考文献55

  • 1苏玉霞,洪洁.妊娠糖尿病发病机制研究进展[J].国际内分泌代谢杂志,2008,4(28):53-55.
  • 2Xiong X, Saunders LD, Wang FL, et al. Gestational diabetes mellitus: prevalence, risk factors, maternal and infant outcomes [J]. Int J Gynaecol Obstet, 2001,75 (3) : 221-228.
  • 3Di Cianni G, Volpe L, Lencioni C, et al. Prevalence and risk factors for gestational diabetes assessed by universal screening [J]. Diabetes Res Clin Pratt, 2003, 62 (2) : 131-137.
  • 4Damm P. Future risk of diabetes in mother and child after gesta- tional diabetes mellitus [ J]. Int J Gynaeeol Obstet, 2009, 104 Suppl 1 : S25-S26.
  • 5Bergmann K, Sypniewska G. Diabetes as a complication of adi- pose tissue dysfunction. Is there a role for potential new biomark- ers? [J]. Clin Chem Lab Med, 2013, 51 (1) : 177-185.
  • 6American Diabetes Association. Gestational diabetes mellitus [J]. Diabetes Care, 2000, 23 Suppl 1 : S77-S79.
  • 7Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man [J]. Diabetologia, 1985, 28 (7) : 412-419.
  • 8Potthoff MJ, Kliewer SA, Mangelsdorf DJ. Endocrine fibroblast growth factors 15/19 and 21: from feast to famine [J]. Genes Dev, 2012, 26 (4) : 312-324.
  • 9Adams AC, Coskun T, Rovira AR, et al. Fundamentals of FGF19 & FGF21 action in vitro and in vivo [J]. PLoS One, 2012, 7 (5): e38438.
  • 10Fu L, John LM, Adams SH, et al. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes [J]. Endocrinology, 2004, 145 (6) : 2594-2603.

共引文献25

同被引文献34

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部